4.84%), although the difference did not reach statistical significance owing to the limited number of patients with HBsAg loss ( Fig. 1D–F ).
← all excerpts
CD55 Variant Associated with Pegylated-interferon α Therapy Response in HBeAg-positive Chronic Hepatitis B Patients.
1
—
—